NEW YORK (GenomeWeb) – NxGen MDx said today its genetic screening and noninvasive prenatal testing will be available to Aetna's members as an in-network benefit, starting Feb. 15. 

The decision by Aetna follows a review of NxGen's products' features, such as full-gene sequencing. The health plan is the third-largest in the US with more than 46 million members. It will cover NxGen MDx's testing at a national level. 

NxGen MDx offers testing for up to 120 various genetic disorders. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.